New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
19:02 EDTEXAR, HBIO, DD, ACMP, MCP, MPEL, WMB, GEOS, AETOn The Fly: After Hours Movers
UP AFTER GUIDANCE: DuPont (DD), up 2.2% after saying it sees FY12 EPS at high end of previous guidance range... Aetna (AET), up 1.5% after backing FY12 EPS view... ALSO HIGHER: Melco Crown Entertainment (MPEL), up 2.8% after a Sterne Agee note positively mentioned the company's Macau casino operations... Harvard Bioscience (HBIO), up 5% after announcing one of its subsidiaries filed for an IPO... DOWN AFTER EARNINGS: Geospace Technologies (GEOS), down 11%... ALSO LOWER: Molycorp (MCP), down 7.7% after announcing its CEO was leaving the company... Exar (EXAR), down 7% after announcing the termination of its CFO... Williams (WMB) after announcing it was taking a $2.4B stake in Access Midstream Partners (ACMP).
News For DD;AET;MPEL;HBIO;GEOS;MCP;EXAR;WMB;ACMP From The Last 14 Days
Check below for free stories on DD;AET;MPEL;HBIO;GEOS;MCP;EXAR;WMB;ACMP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
10:08 EDTAETUnitedHealth retreats after Citi cuts rating on shares
Subscribe for More Information
April 15, 2014
15:18 EDTMCPChina seen exceeding forecast for rare earth stockpiling, SMM says
Subscribe for More Information
06:32 EDTAETPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
April 11, 2014
10:05 EDTAETAetna, Tenet form accountable care collaboration in San Antonio
Aetna (AET), Tenetís (THC) Baptist Health System and HealthTexas Medical Group announced an accountable care collaboration and the introduction of the Aetna Whole Health product in the San Antonio area. The health plans, designed for fully insured customers with employees who live or work in Bexar, Guadalupe, Comal and Kendall counties, will be available on July 1.
April 10, 2014
16:32 EDTEXARExar consolidates product lines
Subscribe for More Information
10:24 EDTMPELMGM holds up amid broader downtrend after analyst recommends stock
Subscribe for More Information
April 9, 2014
13:11 EDTGEOSGeospace management to meet with Dougherty
Meetings to be held in Boston on April 14 and in New York on April 15 hosted by Dougherty.
12:04 EDTDDU.S. corn exports projected to increase 125M bushels
Subscribe for More Information
April 8, 2014
10:18 EDTAETCMS says Medicare Advantage reimbursement to rise in 2015
Subscribe for More Information
09:23 EDTAETLeerink views final rates as favorable for MA plans
Subscribe for More Information
07:42 EDTDDSenate Agriculture, Nutrition & Forestry to hold a hearing
Subscribe for More Information
April 7, 2014
19:13 EDTAETCMS issues 2015 rate announcement for Medicare Advantage and Part D programs
Subscribe for More Information
April 4, 2014
16:42 EDTMCPMolycorp files to sell 23.82M common shares for holders
08:14 EDTDDDuPont, Tate & Lyle contemplating second biochemical plant, Bloomberg says
Subscribe for More Information
April 3, 2014
10:40 EDTDDDuPont $919M verdict thrown out by appeals court, Bloomberg reports
A U.S. court of appeals judge ruled that the trial judge in DuPontís victory over Kolon Industries for the alleged theft of trade secrets related to Kevlar had wrongly excluded evidence and the appeals court threw out the $919.9M court award for DuPont, according to Bloomberg. Reference Link
09:30 EDTDDApple, Pfizer others create 'go slow' patent lobby group, Reuters says
Subscribe for More Information
08:47 EDTEXARExar views any pullback as a buying opportunity, says Cowen
Cowen would view any pullback in Exar as a buying opportunity as they believe a myriad of new product cycles a second half story. The firm cited new product ramps and acquisition synergies as providing a positive risk/reward. Shares are Outperform rated with a $14 price target.
April 2, 2014
18:51 EDTEXAROn The Fly: After Hours Movers
Subscribe for More Information
17:02 EDTEXARExar cuts Q4 revenue view to $28M from $30M-$32M
Consensus $30.88M. "Delays in high reliability programs and software license revenue, as well as continued weakness in the networking market, contributed to a softer than expected month of March. Conversely, our core business in the industrial market performed well," said CEO Louis DiNardo. "Our expectations of a return to growth in the second half of the year remain intact as the pace of our new product introductions and design wins is accelerating."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use